<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03881345</url>
  </required_header>
  <id_info>
    <org_study_id>A002</org_study_id>
    <nct_id>NCT03881345</nct_id>
  </id_info>
  <brief_title>Ongoing Registry of Treatment of Venous Thromboembolism</brief_title>
  <acronym>RRT VTE</acronym>
  <official_title>Russian Registry of Treatment of Venous Thromboembolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medalp Private Surgery Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Medalp Private Surgery Clinic</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ongoing registration of patients with venous thromboembolism treated by means of
      antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data of patients with VTE treated in different Russian medical centers are entered in a
      prospective digital database, and continuously updated.

      There is planned to conduct prospective randomized, cohort and observational studies on the
      site of register
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Anticipated">March 1, 2036</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2036</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Veins patency</measure>
    <time_frame>Baseline, 3 and 12 months post-intervention</time_frame>
    <description>Change in patency target veins assessed by duplex ultrasonography in different follow up periods due to different treatment methods</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postthrombotic syndrome</measure>
    <time_frame>Baseline, 3 and 12 months post-intervention</time_frame>
    <description>the presence and severity of postthrombotic syndrome on the Villalta scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoL SF-36</measure>
    <time_frame>Baseline, 3 and 12 months post-intervention</time_frame>
    <description>Change in Quality of Life (QoL), assessed by &quot;Short form 36&quot; health survey (SF-36). Total scale range: from 0 to 800. SF-36 consists of 8 subscales. Each subscale range: 0 - 100. Subscales are combined using a special algorithm described in the instructions for the SF-36. For total scale the higher value represent the worse QoL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoL AVVQ</measure>
    <time_frame>Baseline, 3 and 12 months post-intervention</time_frame>
    <description>Change in Quality of Life (QoL), assessed by &quot;Aberdeen Varicose Vein Questionnaire&quot; (AVVQ). The AVVQ is a disease-specific QoL questionnaire aimed at venous disease. Total scale range: from 0 to 100, where the higher score represent worse QoL.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <condition>Thromboses, Venous</condition>
  <condition>Thrombosis Embolism</condition>
  <condition>Postthrombotic Syndrome</condition>
  <condition>Pulmonary Embolism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anticoagulants</intervention_name>
    <description>anticoagulation according to the main diagnosis</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open surgery</intervention_name>
    <description>removal of blood clots with open surgery</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thrombolysis</intervention_name>
    <description>removal of blood clots with thrombolysis</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Venous stenting</intervention_name>
    <description>elimination of vein obstruction by stenting</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing any kind of treatment for venous thromboembolism
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  case of venous thrombosis of a limb or pulmonary embolus

        Exclusion Criteria:

          -  no exclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Evgeny Ilyukhin</last_name>
    <phone>+79218451722</phone>
    <email>evgeny@ilyukhin.info</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pirogov Russian National Research Medical University</name>
      <address>
        <city>Moscow</city>
        <zip>190000</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yury Stoyko, MD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <link>
    <url>http://vte.venousregistry.org/index.php</url>
    <description>Russian Registry of Treatment of Venous Thromboembolism (RRT VTE)</description>
  </link>
  <link>
    <url>http://www.phlebounion.ru</url>
    <description>Russian Phlebological Association (RPA)</description>
  </link>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>March 17, 2019</study_first_submitted>
  <study_first_submitted_qc>March 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2019</study_first_posted>
  <last_update_submitted>October 15, 2019</last_update_submitted>
  <last_update_submitted_qc>October 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medalp Private Surgery Clinic</investigator_affiliation>
    <investigator_full_name>Evgeny Ilyukhin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Postthrombotic Syndrome</mesh_term>
    <mesh_term>Postphlebitic Syndrome</mesh_term>
    <mesh_term>Embolism and Thrombosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticoagulants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

